12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Gritstone Bio (NASDAQ:GRTS) stock rose 37.0% to $1.63 during Wednesday’s after-market session. Today’s trading volume for this…
CASI Pharmaceuticals: Q1 Earnings Insights
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Wednesday, May 17, 2023 at 07:35 AM. Here’s what…
CASI Pharmaceuticals Earnings Perspective: Return On Capital Employed
CASI Pharmaceuticals (NASDAQ:CASI) brought in sales totaling $15.26 million during Q4 according to data provided by Benzinga Pro.…
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers GlucoTrack (NASDAQ:GCTK) shares rose 194.1% to $3.5 during Monday’s regular session. Trading volume for this security as…
CASI Pharmaceuticals’ Partner Juventas Announces New Drug Application For CNCT19 Accepted By China National Medical Products Administration
CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces that China National Medical
HC Wainwright & Co. Maintains Buy on CASI Pharmaceuticals, Lowers Price Target to $10
HC Wainwright & Co. analyst Sean Lee maintains CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and lowers the price target from $12 to $10.
CASI Pharmaceuticals Q3 EPS $(0.38) Up From $(0.73) YoY, Sales $10.21M Up From $8.11M YoY
CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.38) per share. This is a 47.95 percent increase over losses of $(0.73) per share from the same period last year. The company reported $10.21 million in
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers
Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
CASI Pharmaceuticals Announces Exit Of Juventas Investment To Strengthen Balance Sheet
CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products ("CASI"), today announced that CASI